基于IGF2的LYTACs用于对细胞外和膜外蛋白的有针对性的降解
Michał Mikitiuk1,2, Jan Barczyński1,2, Przemysław Bielski1
1Recepton Sp. z o.o., Trzy Lipy 3, 80-172 Gdańsk, Poland.
Molecules (Basel, Switzerland)
|November 25, 2023
概括
纯蛋白质色素向仿真体 (LYTACs) 为向降解提供了一个可扩展的替代方案. 这些新型LYTACs有效降解编程死亡联体1 (PD-L1),显示出对传统抗体的增强疗效.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- lysosome-targeting chimeras (LYTACs) 能够对细胞外和膜外蛋白进行有针对性的降解.
- 现有的LYTAC依赖于复杂的糖联体,阻碍了大规模生产.
- 有效的溶酶体降解对于治疗应用至关重要,包括癌症免疫疗法.
研究的目的:
- 开发一种基于蛋白质的新型LYTAC系统,以实现简化和可扩展的生产.
- 研究这些新型LYTACs在向和降解编程死亡带1 (PD-L1) 的有效性.
- 评估蛋白质LYTACs在调节免疫反应中的治疗潜力.
主要方法:
- 使用非糖化胰岛素样生长因子2 (IGF2) 的工程纯蛋白LYTACs.
- 利用IGF2受体/阴离子独立的曼诺-6受体 (IGF2R/CI-M6PR) 途径进行溶酶体贩运.
- 在实验室中评估PD-L1向和降解,比较LYTAC的疗效与抗PD-L1抗体.
主要成果:
- 成功开发出基于蛋白质的LYTACs,生产简单,类似于单克隆抗体制造.
- 通过IGF2R/CI-M6PR通路证明了有效的溶酶体转移和PD-L1的降解.
- 与单独的抗PD-L1抗体相比,在体外实现了PD-L1的优异降解,并增强了生理效应.
结论:
- 基于蛋白质的LYTACs比糖联体具有显著的进步,提供了更好的可扩展性和可访问性.
- 这些新型LYTAC有效地向PD-L1,为免疫检查点阻塞疗法提供了一个有前途的平台.
- 增强的疗效表明,在相关的临床环境中,有可能改善治疗结果.
更多相关视频
10:30Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT
Published on: September 2, 2015
10.3K
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
7.7K
相关概念视频
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Tagging and Fusion Proteins
6.7K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.7K
The Proteasome
851
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
851
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
GPI Anchoring of Proteins in the ER Membrane
4.1K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
4.1K
